ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,759Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 1278

$1.14M Total Retail Price of All Prescriptions

Rank: 10 out of 1278

739 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 739 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 739 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,287 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$117 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 682 643 1 2
CRESTOR 409 391 2 31
AMLODIPINE BESYLATE 306 303 3 5
ZOLPIDEM TARTRATE 247 232 4 16
SIMVASTATIN 201 193 5 3
SYNTHROID 201 191 5 63
LISINOPRIL 193 189 7 1
FUROSEMIDE 163 159 8 10
METFORMIN HCL 159 159 9 4
OMEPRAZOLE 151 145 10 6
BENICAR 150 138 11 107
ATORVASTATIN CALCIUM 143 135 12 15
HYDROCODONE-ACETAMINOPHEN 140 133 S3 13 7
LIOTHYRONINE SODIUM 139 137 14 146
POTASSIUM CHLORIDE 137 135 15 21
BYSTOLIC 136 128 16 136
TAMSULOSIN HCL 130 130 17 32
METOPROLOL SUCCINATE 126 122 18 23
WARFARIN SODIUM 115 114 19 17
LOSARTAN POTASSIUM 112 106 20 19
SERTRALINE HCL 112 108 20 28
PANTOPRAZOLE SODIUM 104 104 22 34
DONEPEZIL HCL 90 90 23 48
DIOVAN 86 86 24 44
PRAVASTATIN SODIUM 80 79 25 14
CLOPIDOGREL 80 79 25 45
NAMENDA 76 76 27 77
AZOR 73 71 28 301
ESCITALOPRAM OXALATE 72 61 29 134
ESTRADIOL 71 67 R 30 71
ALLOPURINOL 68 67 31 36
TRILIPIX 67 67 32 153
CITALOPRAM HBR 64 62 33 22
METOPROLOL TARTRATE 61 60 34 9
JANUVIA 59 58 35 68
PREDNISONE 59 59 35 52
LYRICA 59 58 35 104
PRADAXA 58 58 38 278
CARVEDILOL 56 55 39 39
PLAVIX 56 56 39 64
JANUMET 55 55 41 210
TRAMADOL HCL 55 36 41 25
HYDROCHLOROTHIAZIDE 55 51 41 8
AZITHROMYCIN 54 51 44 37
DIGOXIN 54 53 44 79
LEVEMIR FLEXPEN 53 53 46 217
TRIAMTERENE-HCTZ 52 52 47 43
OXYCONTIN 51 47 S2 48 89
BENAZEPRIL HCL 51 51 48 81
FLUTICASONE PROPIONATE 50 44 50 24
TESTOSTERONE CYPIONATE 50 42 S3 50 243
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.